Fuller & Thaler Asset Management
TNDM icon

Fuller & Thaler Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Fuller & Thaler Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-87,192
Closed -$7.7M – 549
2021
Q1 		$7.7M Buy
87,192
+1,412
+2% +$131K 0.05% 232
2020
Q4 		$8.21M Buy
85,780
+1,817
+2% +$187K 0.08% 218
2020
Q3 		$9.53M Sell
83,963
-44,149
-34% -$4.64M 0.12% 171
2020
Q2 		$12.7M Buy
128,112
+2,935
+2% +$234K 0.17% 147
2020
Q1 		$8.05M Sell
125,177
-1,246
-1% -$87.3K 0.14% 149
2019
Q4 		$7.54M Sell
126,423
-3,501
-3% -$216K 0.08% 193
2019
Q3 		$7.66M Buy
129,924
+141
+0.1% +$9K 0.09% 177
2019
Q2 		$8.37M Buy
129,783
+529
+0.4% +$34.1K 0.1% 168
2019
Q1 		$8.21M Buy
+129,254
New +$6.79M 0.1% 158

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Fuller & Thaler Asset Management's TNDM Position: Q2 2021 in Review

Fuller & Thaler Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 87,192 shares — an estimated $7.7M sold.

Fuller & Thaler Asset Management first reported a position in TNDM in Q1 2019 and held it in 9 quarters. The position peaked at $12.7M in Q2 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Fuller & Thaler Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 87,192 Tandem Diabetes Care shares in Q2 2021, an estimated $7.7M.
  • Fuller & Thaler Asset Management first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 9 quarters.
  • Fuller & Thaler Asset Management's Tandem Diabetes Care position peaked at $12.7M in Q2 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.